Jodi Devlin

Jodi Devlin

Chief of Clinical OperationsatTriSalus Life Sciences· In proxies 2023–2024

Pay in FY2024TriSalus Life Sciences stock -40.7% the same year

Jodi Devlin was paid $1.4M in FY2024 (Dec). TriSalus Life Sciences stock fell 40.7% that year.

Pay$100 in the stock at the end of FY22 → $50
Pay is from the Summary Compensation Table of each TriSalus Life Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. TriSalus Life SciencesPublic company · 3 yr
    • Chief of Clinical Operations2023 – Present · 3 yrStock in role -61%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?